Page last updated: 2024-11-05

thalidomide and Ametropia

thalidomide has been researched along with Ametropia in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strömland, K1
Miller, MT1
Cant, JS1

Other Studies

2 other studies available for thalidomide and Ametropia

ArticleYear
Refractive evaluation in thalidomide embryopathy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1992, Volume: 230, Issue:2

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Cornea; Eye Abnormalities; Female; Huma

1992
Minor ocular abnormalities associated with thalidomide.
    Lancet (London, England), 1966, May-21, Volume: 1, Issue:7447

    Topics: Abnormalities, Drug-Induced; Child, Preschool; Choroid; Eye Abnormalities; Female; Humans; Infant; I

1966